Last reviewed · How we verify
Prevantics 3.15 % / 70 % Swabstick
Prevantics is a topical antiseptic swabstick containing chlorhexidine gluconate and isopropyl alcohol that kills microorganisms on skin to prevent surgical site infections.
Prevantics is a topical antiseptic swabstick containing chlorhexidine gluconate and isopropyl alcohol that kills microorganisms on skin to prevent surgical site infections. Used for Skin antisepsis prior to surgical procedures, Prevention of surgical site infections.
At a glance
| Generic name | Prevantics 3.15 % / 70 % Swabstick |
|---|---|
| Also known as | Prevantics Maxi Swabstick |
| Sponsor | Professional Disposables International, Inc. |
| Drug class | Topical antiseptic |
| Modality | Small molecule |
| Therapeutic area | Infection Prevention / Surgical Site Prophylaxis |
| Phase | Phase 3 |
Mechanism of action
The product combines two antimicrobial agents: chlorhexidine gluconate (3.15%) disrupts bacterial cell membranes and denatures proteins, while isopropyl alcohol (70%) provides rapid antimicrobial activity through protein denaturation and cell lysis. Together, these agents provide broad-spectrum antimicrobial coverage for skin antisepsis prior to medical procedures.
Approved indications
- Skin antisepsis prior to surgical procedures
- Prevention of surgical site infections
Common side effects
- Skin irritation
- Contact dermatitis
- Allergic reaction
Key clinical trials
- Pilot Evaluation of Two Test Materials With a Positive Control When Used as a Patient Preoperative Skin Preparation (PHASE3)
- Preoperative Skin Preparation Study to Evaluate the Antimicrobial Capabilities of Four Test Substances (PHASE3)
- Comparative Study of Antimicrobial Effectiveness (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: